Literature DB >> 21416126

Protective effect of Justicia gendarussa Burm.f. on carrageenan-induced inflammation.

S K Kavitha1, V Viji, K Kripa, A Helen.   

Abstract

The present study focuses on the anti-inflammatory activity of Justicia gendarussa Burm.f. on an acute model of inflammation: the carrageenan-induced paw edema assay. Methanolic extract of J. gendarussa (JRM) roots at a dose of 100 mg/kg significantly inhibited edema formation 5 h after carrageenan induction. JRM inhibited carrageenan-elicited total cycloxygenase activity, 5-lipoxygenase and 15-lipoxygenase activities in blood mononuclear cells of rats, decreased neutrophil infiltration in paw tissue as shown by low myeloperoxidase activity, and also caused a 53% inhibition in cyclooxygenase-2 activity in paw tissue. Purification of JRM by liquid-liquid partitioning yielded an ethyl acetate fraction of JRM that showed interleukin-6 downregulation potential and the ability to inhibit prostaglandin E2 production in vivo. The present investigation provides pharmacological evidence to support the folklore claim that J. gendarussa is an anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21416126     DOI: 10.1007/s11418-011-0524-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  26 in total

1.  Biphasic development of carrageenin edema in rats.

Authors:  R Vinegar; W Schreiber; R Hugo
Journal:  J Pharmacol Exp Ther       Date:  1969-03       Impact factor: 4.030

2.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

Authors:  J C Fantone; P A Ward
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

3.  Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation.

Authors:  F Nantel; D Denis; R Gordon; A Northey; M Cirino; K M Metters; C C Chan
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 4.  New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways.

Authors:  A González-Périz; J Clària
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

5.  Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

Authors:  Y Zhang; A Shaffer; J Portanova; K Seibert; P C Isakson
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

Review 6.  The role of leukotrienes in inflammation.

Authors:  W R Henderson
Journal:  Ann Intern Med       Date:  1994-11-01       Impact factor: 25.391

7.  Mediators of the inflammation induced in the rat paw by carrageenin.

Authors:  P Crunkhorn; S C Meacock
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

8.  Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach.

Authors:  B M Peskar
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

9.  Stem cells and CAM.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2006-06       Impact factor: 2.629

10.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.

Authors:  J P Portanova; Y Zhang; G D Anderson; S D Hauser; J L Masferrer; K Seibert; S A Gregory; P C Isakson
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  2 in total

1.  Vasculoprotective effects of Centella asiatica, Justicia gendarussa and Imperata cylindrica decoction via the NOXs-ROS-NF-κB pathway in spontaneously hypertensive rats.

Authors:  Erna Sulistyowati; Ren-Long Jan; Shu-Fen Liou; Ying-Fu Chen; Bin-Nan Wu; Jong-Hau Hsu; Jwu-Lai Yeh
Journal:  J Tradit Complement Med       Date:  2019-06-24

2.  Indonesian herbal medicine prevents hypertension-induced left ventricular hypertrophy by diminishing NADPH oxidase-dependent oxidative stress.

Authors:  Erna Sulistyowati; Jong-Hau Hsu; Yuan-Bin Cheng; Fang-Rong Chang; Ying-Fu Chen; Jwu-Lai Yeh
Journal:  Oncotarget       Date:  2017-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.